These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of ocular tumors with technetium-99m-MIBI: planar pinhole technique or SPECT? Alonso O; Núñez M; Cánepa J; Guisoli P; Mut F; Lago G; Touya E J Nucl Med Technol; 2000 Jun; 28(2):85-7. PubMed ID: 10824618 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma. Blend MJ; Hyun H; Patel B; Sullivan K; Salk D J Nucl Med; 1996 Feb; 37(2):252-7. PubMed ID: 8667055 [TBL] [Abstract][Full Text] [Related]
5. Role of radioimmunoscintigraphy and SPET in the diagnosis of patients with malignant melanoma. Sergieva S; Goranov K; Piperkova E; Tzingilev D; Trojanova P; Peitcheva E; Kulkin V Nucl Med Commun; 1994 Mar; 15(3):168-72. PubMed ID: 8190407 [TBL] [Abstract][Full Text] [Related]
6. Radioimmunoscintigraphy with 99mTc-225.28S-F(ab')2 in cutaneous and ocular melanomas: cases of particular clinical interest. Salzillo F; Mele M; Lombardo T; Delle Noci N; Minervini C; D'Addabbo A J Nucl Biol Med (1991); 1993 Dec; 37(4):191-7. PubMed ID: 8172959 [TBL] [Abstract][Full Text] [Related]
7. Scintigraphic visualization of ocular melanoma with Tc-99m glutathione. Tutuş A; Erkiliç K; Ercan MT; Kontaş O; Aydin M; Doğan H Ann Nucl Med; 1997 May; 11(2):143-6. PubMed ID: 9212895 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy with Tc-99m labeled monoclonal antibody 170H.82 in suspected primary, recurrent, or metastatic breast cancer. Lind P; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Omann J; Dinges HP; Boniface G Clin Nucl Med; 1997 Jan; 22(1):30-4. PubMed ID: 8993870 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer. de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020 [TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphy results in the comparison of ocular with cutaneous melanoma]. Löffler KU; Bräutigam P; Simon J; Althauser SR; Moser E; Witschel H Ophthalmologe; 1994 Aug; 91(4):529-32. PubMed ID: 7950129 [TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy with anti-225.28S for ocular melanoma--a comparison with histology and immunohistochemistry. Bräutigam P; Loeffler KU; Krause T; Högerle S; Simon J; Moser E Nuklearmedizin; 1997 Mar; 36(2):42-6. PubMed ID: 9090646 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of ocular melanoma immunoscintigraphy. Janković Z; Pucar D; Jauković L; Ajdinović B J BUON; 2006; 11(3):347-50. PubMed ID: 17309161 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography. Wahl RL; Swanson NA; Johnson JW; Natale R; Petry NA; Mallette S; Kasina S; Reno J; Sullivan K; Abrams P Am J Physiol Imaging; 1992; 7(2):48-58. PubMed ID: 1419120 [TBL] [Abstract][Full Text] [Related]
14. Preoperative diagnosis of ovarian carcinoma with a novel monoclonal antibody. Lieberman G; Buscombe JR; Hilson AJ; Reid WM; Thakrar D; Maclean AB Am J Obstet Gynecol; 2000 Sep; 183(3):534-40. PubMed ID: 10992170 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunoscintigraphy of colorectal carcinoma using technetium-99m-labeled, totally human monoclonal antibody 88BV59H21-2. Gulec SA; Serafini AN; Moffat FL; Vargas-Cuba RD; Sfakianakis GN; Franceschi D; Crichton VZ; Subramanian R; Klein JL; De Jager RL Cancer Res; 1995 Dec; 55(23 Suppl):5774s-5776s. PubMed ID: 7493345 [TBL] [Abstract][Full Text] [Related]
16. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients. Blend MJ; Ronan SG; Salk DJ; Gupta TK J Clin Oncol; 1992 Aug; 10(8):1330-7. PubMed ID: 1634923 [TBL] [Abstract][Full Text] [Related]
17. Radioimmunodetection and radioimmunotherapy of malignant melanoma. A review. Liewendahl K; Pyrhönen S Acta Oncol; 1993; 32(7-8):717-21. PubMed ID: 8305217 [TBL] [Abstract][Full Text] [Related]
18. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma. Magnani P; Paganelli G; Modorati G; Zito F; Songini C; Sudati F; Koch P; Maecke HR; Brancato R; Siccardi AG; Fazio F J Nucl Med; 1996 Jun; 37(6):967-71. PubMed ID: 8683323 [TBL] [Abstract][Full Text] [Related]
19. Clinical role of 123I-IMP SPECT for the differential diagnosis of ocular malignant melanoma: a time-course analysis. Abe K; Sasaki M; Koga H; Kaneko K; Sawamoto H; Yoshikawa H; Honda H Nucl Med Commun; 2007 Jul; 28(7):567-73. PubMed ID: 17538399 [TBL] [Abstract][Full Text] [Related]
20. [Values and limitations of radioimmunoscintigraphy with MoAb 225-28S in the diagnosis of posterior uveal melanoma]. Cavazza S; Tassoni A; Abbati A J Fr Ophtalmol; 1992; 15(6-7):395-9. PubMed ID: 1294595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]